BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26503216)

  • 1. Interleukin-15-transferred cytokine-induced killer cells elevated anti-tumor activity in a gastric tumor-bearing nude mice model.
    Peng Z; Liang W; Li Z; Xu Y; Chen L
    Cell Biol Int; 2016 Feb; 40(2):204-13. PubMed ID: 26503216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
    Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
    Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells.
    Kim YJ; Lim J; Kang JS; Kim HM; Lee HK; Ryu HS; Kim JY; Hong JT; Kim Y; Han SB
    Arch Pharm Res; 2010 Nov; 33(11):1789-95. PubMed ID: 21116782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro.
    Zhao Q; Zhang H; Li Y; Liu J; Hu X; Fan L
    J Exp Clin Cancer Res; 2010 Aug; 29(1):118. PubMed ID: 20799994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysaccharides from Hedyotis diffusa enhance the antitumor activities of cytokine-induced killer cells.
    Ma C; Wei Y; Liu Q; Xin Y; Cao G; Wang X; Yang P
    Biomed Pharmacother; 2019 Sep; 117():109167. PubMed ID: 31387180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice.
    Shi S; Tao L; Song H; Chen L; Huang G
    APMIS; 2014 May; 122(5):380-91. PubMed ID: 24628659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic therapeutic effects of cytokine-induced killer cells and temozolomide against glioblastoma.
    Jin J; Joo KM; Lee SJ; Jo MY; Kim Y; Jin Y; Kim JK; Ahn JM; Yoon MJ; Lim J; Nam DH
    Oncol Rep; 2011 Jan; 25(1):33-9. PubMed ID: 21109954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CIK cells stimulated with combination of IL-2 and IL-15 provide an improved cytotoxic capacity against human lung adenocarcinoma.
    Wei C; Wang W; Pang W; Meng M; Jiang L; Xue S; Xie Y; Li R; Hou Z
    Tumour Biol; 2014 Mar; 35(3):1997-2007. PubMed ID: 24104501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
    Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
    Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model.
    Kim HM; Lim J; Kang JS; Park SK; Lee K; Kim JY; Kim YJ; Hong JT; Kim Y; Han SB
    Int Immunopharmacol; 2009 Mar; 9(3):375-80. PubMed ID: 19105981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of in vivo labeled cytotoxic T lymphocytes and cytokine-induced killer cells migration and distribution of subcutaneous gastric tumor model in nude mice].
    Wu ZY; DU XH; Xu YX; Li L; Liu JC; Wang JJ; Li ZX
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):403-6. PubMed ID: 20367940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
    Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic effects of cytokine-induced killer cells combined with CCL21/IL15 armed oncolytic adenovirus in TERT-positive tumor cells.
    Ye JF; Lin YQ; Yu XH; Liu MY; Li Y
    Int Immunopharmacol; 2016 Sep; 38():460-7. PubMed ID: 27380620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing effects of Huaier Granule combined with DC-CIK on nude mice transplanted with colon carcinoma cell line.
    Sun WW; Dou JX; Zhang L; Qiao LK; Shen N; Zhao Q; Gao WY
    Oncotarget; 2017 Jul; 8(28):46081-46089. PubMed ID: 28537906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
    Jiang J; Xu N; Wu C; Deng H; Lu M; Li M; Xu B; Wu J; Wang R; Xu J; Nilsson-Ehle P
    Anticancer Res; 2006; 26(3B):2237-42. PubMed ID: 16821594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway.
    Iudicone P; Fioravanti D; Cicchetti E; Zizzari IG; Pandolfi A; Scocchera R; Fazzina R; Pierelli L
    Hum Immunol; 2016 Dec; 77(12):1239-1247. PubMed ID: 27615504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine treatment enhanced the anti-tumor effect of cytokine induced killer cells by depletion of CD4
    Zhao P; Zhu D; Zhang Z; Han B; Gao D; Wei X; Xie X; Li C; Sun W; Wang Q; Guo Q
    Immunol Lett; 2017 Jan; 181():36-44. PubMed ID: 27867030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition.
    Wei F; Rong XX; Xie RY; Jia LT; Wang HY; Qin YJ; Chen L; Shen HF; Lin XL; Yang J; Yang S; Hao WC; Chen Y; Xiao SJ; Zhou HR; Lin TY; Chen YS; Sun Y; Yao KT; Xiao D
    Oncotarget; 2015 Oct; 6(33):35023-39. PubMed ID: 26418951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma.
    Merker M; Wagner J; Kreyenberg H; Heim C; Moser LM; Wels WS; Bonig H; Ivics Z; Ullrich E; Klingebiel T; Bader P; Rettinger E
    Front Immunol; 2020; 11():581468. PubMed ID: 33193388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.